External beam radiotherapy (RT) has long played a crucial role in the treatment of
glioblastoma. Over the past several decades, significant advances in RT treatment and …

Purpose The extent of resection (EOR) is an independent prognostic factor for overall
survival (OS) in adult patients with Glioma Grade 4 (GG4). The aim of the neuro-oncology …

Glioblastoma is a highly heterogeneous disease, with variations observed at both
phenotypical and molecular levels. Personalized therapies would be facilitated by non …

Purpose Primary malignant brain and other central nervous system tumors are rare cancers
that have shown rising mortality rates in recent years. To elucidate potential factors involved …

The incidence of glioblastoma (GBM) in the elderly population is slowly increasing in
Western countries. Current management includes surgery, radiation therapy (RT) and …

Glioblastoma is an aggressive primary brain tumor with devastatingly poor prognosis.
Multiple studies have shown the benefit of wider extent of resection (EOR) on patient overall …

Management of patients with glioblastoma (GBM) often includes radiation (RT) and
temozolomide (TMZ). The association between severe treatment-related lymphopenia (TRL) …

Introduction Glioblastoma (GBM), the most lethal primary brain malignancy, is divided into
histological (hist-GBM) and molecular (mol-GBM) subtypes according to the 2021 World …

Background There are controversial results concerning the prognostic implication of TERT
promoter mutation in glioma patients concerning MGMT status. In this meta-analysis, we …

Maximal safe resection is an essential part of the multidisciplinary care of patients with
glioblastoma. A growing body of data shows that gross total resection is an independent …